One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Aims+Scope/Editorial Board/ Publication information
doi : 10.1016/S0167-8140(24)03530-8
Volume 200, November 2024, 110552
Call For Papers: Radiotherapy & Oncology and The Lancet Oncology collaboration
Stereotactic ablative radiotherapy for oligoprogressive solid tumours: A systematic review and meta-analysis
Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trial
Single preoperative radiation therapy with delayed surgery for low-risk breast cancer: Oncologic outcome, toxicity and cosmesis of the SPORT-DS phase I trial
Single pre-operative radiation therapy (SPORT-CK) trial for low-risk breast cancer: Early results of a phase 2 study
Local control and toxicity after stereotactic radiotherapy in brain metastases patients and the impact of novel systemic treatments
Blood biomarkers for cardiac damage during and after radiotherapy for esophageal cancer: A prospective cohort study
Dosimetric predictors of acute and late gastrointestinal toxicities in stereotactic online adaptive magnetic resonance-guided radiotherapy (SMART) for locally advanced pancreatic adenocarcinoma
Post-hoc analysis of clinicopathological factors affecting lateral lymph node metastasis based on STELLAR study for rectal cancer
Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable esophageal squamous cell carcinoma: A pooled analysis of randomized clinical trials
Analysis of re-recurrent rectal cancer after curative treatment of locally recurrent rectal cancer
Physical activity at diagnosis is associated with tumor downstaging after neoadjuvant chemoradiotherapy in patients with rectal cancer
Patterns of lymph node involvement for oral cavity squamous cell carcinoma
MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells
Induction plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy in elderly patients with locoregionally advanced nasopharyngeal carcinoma
Management of post-radiation carotid blowout syndrome in patients with head and neck cancer: A systematic review
Risk factors for recurrent laryngeal nerve injury in microwave ablation of thyroid nodules: A multicenter study
Clinical target volume design and dose in carbon-ion radiation therapy for sinonasal mucosal melanoma
De-escalated radiation for human papillomavirus virus-related oropharyngeal cancer: Who, why, what, where, when, how, how much…and what next?
Fructose 1,6-bisphosphate aldolase: A promising prognostic marker for oral cancer and its role in radiotherapy response
Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing
Cumulative rib fracture risk after stereotactic body radiotherapy in patients with localized non-small cell lung cancer
Robust localization of poorly visible tumor in fiducial free stereotactic body radiation therapy☆
Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trial
Undetectable PSA predicts outcome after salvage radiotherapy for biochemical recurrence following radical prostatectomy
Pretreatment plasma osteopontin level as a marker of response to curative radiotherapy and hormonal treatment for prostate cancer
Adapting outside the box: Simulation-free MR-guided stereotactic ablative radiotherapy for prostate cancer
The mitotic rate as a prognostic biomarker after preoperative radiotherapy for high-grade limb/trunk soft tissue sarcoma
A phase II randomized trial of talimogene laherparepvec oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors
Assessment of integrated electromagnetic tracking for dwell position monitoring in a clinical HDR brachytherapy setting for prostate cancer
Daily CBCT-based dose calculations for enhancing the safety of dose-escalation in lung cancer radiotherapy
Semi-automated reproducible target transfer for cardiac radioablation – A multi-center cross-validation study within the RAVENTA trial
Talazoparib enhances resection at DSBs and renders HR-proficient cancer cells susceptible to Polθ inhibition
In vitro-irradiated cancer vaccine enhances anti-tumor efficacy of radiotherapy and PD-L1 blockade in a syngeneic murine breast cancer model
RSPO3 regulates the radioresistance of Non-Small cell lung cancer cells via NLRP3 Inflammasome-Mediated pyroptosis
Enhanced radiosensitivity of pancreatic cancer achieved through inhibition of Cyclin-dependent kinase 1
Brachial plexopathy following stereotactic body radiation therapy in apical lung malignancies: A dosimetric pooled analysis of individual patient data
Deep learning-assisted interactive contouring of lung cancer: Impact on contouring time and consistency
Machine learning and deep learning prediction of patient specific quality assurance in breast IMRT radiotherapy plans using Halcyon specific complexity indices
The added value of a new high-performance ring-gantry CBCT imaging system for prostate cancer patients
Evaluating coronary arteries and predicting MACEs using CCTA in lung cancer patients receiving chemotherapy or chemoradiotherapy
Association of the combined stereotactic radiosurgery and embolization strategy and long-term outcomes in brain arteriovenous malformations with a volume >10Â ml: A nationwide multicenter observational prospective cohort study
A patient-specific auto-planning method for MRI-guided adaptive radiotherapy in prostate cancer
Clinical implementation of deep learning robust IMPT planning in oropharyngeal cancer patients: A blinded clinical study
Fully automated radiotherapy treatment planning: A scan to plan challenge
Automated dose evaluation on daily cone-beam computed tomography for breast cancer patients
Recording and reporting of ultra-high dose rate “FLASH� delivery for preclinical and clinical settings
Concerns regarding the use of only phase 2 study to Justify palliative radiotherapy vs. Palliative chemo-radiotherapy in unresectable head and neck cancer
